Plain-English translation of NCT05230732 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called low-level tragus stimulation (LLTS), which uses a small device with electrodes placed on your ear to gently stimulate a nerve. Researchers believe this stimulation may help reduce inflammation and improve how well your heart works in people with systolic heart failure. The study will measure whether the treatment helps you walk farther, improves your quality of life, and changes the way your nervous system controls your heart.
Heart failure is common in older adults and current treatments don't work well enough for everyone. This trial exists because researchers have found that stimulating a nerve in your ear might help calm the body's stress response and reduce the inflammation that damages the heart, offering a new option for patients who need better treatments.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive either the active ear stimulation or a sham (placebo) treatment that looks the same but does not deliver the stimulation. You will wear the device for one hour each day for 12 weeks. At the beginning and end of the 3-month period, you'll visit the clinic to take a walking test, answer questions about your quality of life, have your heart rhythm measured, and provide blood samples so researchers can track inflammation markers.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
United States